Popular Trials
Janus Kinase (JAK) Inhibitor
Continued Itacitinib Treatment for Myelofibrosis
Recruiting1 awardPhase 2
Fort Wayne, Indiana
This trial provides the medication itacitinib to participants from previous studies who may benefit from continued treatment. Itacitinib helps reduce inflammation by blocking specific proteins that cause it.
Popular Filters
Trials for BOS Patients
LAM-001 for Bronchiolitis Obliterans Syndrome
Recruiting0 awardsPhase 2
San Francisco, California
This trial will investigate the safety and effectiveness of inhaled sirolimus to slow bronchiolitis obliterans syndrome (BOS) progression in lung transplant recipients. Participants will be randomly assigned to inhale sirolimus or placebo for 48 weeks and attend 10 visits.
Immunomodulator
ARINA-1 for Bronchiolitis Obliterans Syndrome
Recruiting2 awardsPhase 3
Saint Louis, Missouri
This trial is testing ARINA-1, a new treatment added to usual care, for lung transplant patients at risk of a serious lung condition called BOS. The goal is to see if ARINA-1 can prevent the condition from getting worse and improve patients' quality of life. The trial involves periodic health monitoring to track progress and any side effects.
Janus Kinase Inhibitor
Ruxolitinib for Lung Dysfunction Post Stem Cell Transplant
Recruiting1 awardPhase 2
Cincinnati, Ohio
This trial is testing whether a new combination of drugs can help treat a common and serious side effect of a stem cell transplant that often leads to long-term problems or even death.
Immunosuppressant
L-CsA + Standard of Care for Bronchiolitis Obliterans Syndrome
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is testing how safe and effective L-CsA plus Standard of Care is in treating Breathing Obstruction Syndrome in people who have had either a single or double lung transplant.
Neutrophil Elastase Inhibitor
Alvelestat for Bronchiolitis Obliterans Syndrome
Recruiting1 awardPhase 1 & 2
Bethesda, Maryland
This trial is testing a new drug, alvelestat (MPH966), to see if it's safe and effective in treating bronchiolitis obliterans syndrome (BOS). BOS is a complication people can experience after hematopoietic stem cell transplant.
Trials With No Placebo
Immunomodulator
ARINA-1 for Bronchiolitis Obliterans Syndrome
Recruiting2 awardsPhase 3
Saint Louis, Missouri
This trial is testing ARINA-1, a new treatment added to usual care, for lung transplant patients at risk of a serious lung condition called BOS. The goal is to see if ARINA-1 can prevent the condition from getting worse and improve patients' quality of life. The trial involves periodic health monitoring to track progress and any side effects.
Janus Kinase Inhibitor
Ruxolitinib for Lung Dysfunction Post Stem Cell Transplant
Recruiting1 awardPhase 2
Cincinnati, Ohio
This trial is testing whether a new combination of drugs can help treat a common and serious side effect of a stem cell transplant that often leads to long-term problems or even death.
Immunosuppressant
L-CsA + Standard of Care for Bronchiolitis Obliterans Syndrome
Recruiting2 awardsPhase 3
Phoenix, Arizona
This trial is testing how safe and effective L-CsA plus Standard of Care is in treating Breathing Obstruction Syndrome in people who have had either a single or double lung transplant.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.